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Case Reports 
Dermatomyositis associated with small cell 
carcinoma of the lung: dramatic response to 
corticosteroid therapy 
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Department of Medicine, Queen Margaret Hospital, Dunfermline, Fife, U.K. 
Introduction 
The exact relationship between dermatomyositis and neo- 
plasia remains a point of debate (1). In association with 
malignancy, dermatomyositis is classically regarded as re- 
sistant to treatment with steroids, and results after excision 
or treatment of the tumour are variable (2). We describe 
a patient who showed a dramatic response to steroid 
treatment with marked enhancement of her quality of life. 
Case Report 
A 52-year-old female smoker with a history of previous 
alcohol excess presented with a 3-month history of a dry 
cough with weight loss. For the previous 2 months, she had 
experienced debilitating weakness especially on standing 
from sitting and on lifting her arms above her head. She 
had become bed-bound for 1 month. Complete dysphagia 
for solid food prompted admission, when she admitted to 
dysphagia for liquids over the proceeding week. She had 
abstained from alcohol for 2 months. 
On examination, the patient was thin and dehydrated. 
There was a widespread ‘scaly and eczematous purplish 
rash, especially on areas exposed to sunlight and around the 
eyes (Plate 1). There was no finger clubbing but the nailbeds 
were erythematous. In the chest, there were signs of a 
collapsed left lower lobe. There were no stigmata of chronic 
liver disease. Examination of the limbs demonstrated a 
marked proximal weakness with muscles tender and woody 
on palpation. The upper limbs displayed flexion contrac- 
tures at the elbows. There was no evidence of a peripheral 
neuropathy. Urinalysis was negative. 
A clinical diagnosis of bronchial carcinoma complicated 
by dermatomyositis was made. Chest radiography and 
computed tomographic (CT) scan of thorax confirmed left 
lower lobe collapse with widening of the mediastinum. 
Bronchoscopy demonstrated tumour occluding the left 
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lower lobe bronchus with histology of small cell undiffer- 
entiated carcinoma. Creatinine phosphokinase (CK) was 
elevated at 1221 U l- ’ on admission. Barium swallow 
showed slow initiation of swallowing with no intraluminal 
lesion, but extrinsic compression below the level of the left 
main bronchus was noted. An electrocardiograph series was 
normal. 
The patient was admitted to hospital and received intra- 
venous fluid rehydration. She remained unable to swallow 
and so weak that she could not sit up in bed without 
assistance. Methylprednisolone 40 mg daily was given 
intravenously. Symptomatic relief was evident within 3 
PLATE 1 Purplish and eczematous rash in sun-exposed 
chest and shoulders and fingers. 
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days of starting steroids when the serum CK had fallen to 
440 U I- ‘. After 1 week of treatment with steroids, she was 
able to mobilize and could wash and dress independently. 
Her swallowing improved such that she could take a soft 
solid diet. Her muscles were no longer tender and they had 
lost their woody feel. The apparent contractures of the 
upper limb resolved without formal physiotherapy. Treat- 
ment was converted to soluble prednisolone 30 mg daily. 
On Day 9, the serum CK was 188 U l- ’ and she was 
allowed home prior to commencing cyclical combination 
chemotherapy. She remained well on oral steroid therapy 
without clinical evidence of relapse. Unfortunately, she was 
found dead in bed at home just before her second cycle of 
chemotherapy was due, some 5 weeks after discharge from 
hospital. Permission for an autopsy was not granted. 
I+scussion 
We report a case of dermatomyositis temporally associated 
with diagnosing small cell carcinoma of the lung. A dra- 
matic clinical and biochemical response to corticosteroid 
therapy was demonstrated. 
In this case, the carcinoma was proven. Muscle biopsy 
was not performed to confirm dermatomyositis, but the 
diagnosis was supported by the clinical history and exami- 
nation findings supported by an elevated serum CK. Her 
muscles, rash and oesophageal dysmotility all displayed an 
impressive subjective and objective response to treatment. 
There was no relapse in her condition on converting from 
intravenous methylprednisolone to soluble prednisolone. In 
this individual, treatment with steroids yielded a dramatic 
and worthwhile improvement in her quality of life. 
Dermatomyositis in adults may be idiopathic, associated 
with collagen vascular disease or associated with neoplasia. 
Malignancy is noted in up to 30% of cases of adult 
dermatomyositis (3). Mortality rates of up to 50% have 
been reported due to the underlying malignancy and lack of 
response to therapy (4) Despite such therapeutic nihilism, 
we suggest that a trial of steroid therapy is warranted in 
patients with dermatomyositis, even if associated with a 
tumour with little chance of cure. The possible benefits in 
terms of enhanced quality of life are worthwhile. 
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Hypomagnesaemic tetany associated with repeated 
courses of intravenous tobramycin in a patient with 
cystic fibrosis 
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Introduction We report the case of an adult patient with cystic fibrosis 
who developed hypomagnesaemic, hypocalcaemic tetany 
following repeated courses of intravenous tobramycin. 
Magnesium deficiency is usually secondary to either 
gastrointestinal or renal loss. The kidneys control the fine 
regulation of magnesium metabolism, re-absorption 
occurring mostly in the thick ascending limb of Henle 
(50-70%) and the proximal convoluted tubule (15-20%) (1). 
In normal homeostasis, urinary magnesium loss can be 
Intravenous aminoglycoside therapy may cause reversible 
renal tubular damage and symptomatic hypomagnesaemia. 
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